5 Overpriced Stocks to Ditch Now

It's a fool's game to hold these stocks. Get out while you can.

      View All  
5 Overpriced Stocks to Ditch Now

Merck & Co.

MerckLogo e1282588089406 5 Overpriced Stocks to Ditch NowThe only big pharma company that may need to be sold more is Merck & Co. (MRK). It’s in the same boat as BMY, except earnings aren’t even expected to recover next year — staying flat at $3.49 — and long-term growth is a mere 2%.

Yeah, I know you love the 3.8% yield, but the stock is overpriced by more than 3.8%. Again, even if I’m super generous and give an undeserving 9x estimate, the stock isn’t worth much more than $30, and trades at $48.


Article printed from InvestorPlace Media, http://investorplace.com/2013/11/5-overpriced-stocks-to-sell/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.